| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0054 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0057 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |